A Vanderbilt University patent discloses new muscarinic M4 receptor positive allosteric modulators and agonists reported to be useful for the treatment of Alzheimer’s disease, pain, schizophrenia, ...

More information: Michael S. Poslunsey et al, Discovery of VU0467319: an M1 Positive Allosteric Modulator Candidate That Advanced into Clinical Trials, ACS Chemical Neuroscience (2024). DOI: 10. ...